Prevalence of the Metabolic Syndrome and its Relation to Cardiovascular Disease in an Elderly Chinese Population
Yao He, MD, PhD*, ,*,
Bin Jiang, MD, PhD ,
Jie Wang, MD, PhD ,
Kang Feng, MD*,
Qing Chang, MD*,
Li Fan, MD¶,
Xiaoying Li, MD¶ and
Frank B. Hu, MD, PhD ,||,a
* Institute of Geriatrics, Chinese PLA General Hospital, Beijing, China
Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts
Department of Acupuncture, Chinese PLA General Hospital, Beijing, China
Department of Emergency, General Hospital of Chinese Peoples Armed Forces, Beijing, China
¶ Department of Geriatric Cardiology, Chinese PLA General Hospital, Beijing, China
|| Channing Laboratory, Department of Medicine, Harvard Medical School and Brigham and Womens Hospital, Boston, Massachusetts

View larger version (32K):
[in a new window]
|
Figure 1 Disease-specific prevalence of the 2,334 Chinese elderly patients with none, one, or more components (cp) of metabolic syndrome (MetS) by U.S. National Cholesterol Education Program Adult Treatment Panel III (NCEP) (top) and by International Diabetes Federation (IDF) (bottom) criteria. CHD = coronary heart disease; CVD = one or more of the three outcomes (CHD, stroke, or PAD); PAD = peripheral arterial disease.
|
|
|